Brief Intervention in Substance Use in Adolescent Psychiatric Patients

Not Applicable

Completed

• Conditions: Substance-Related Disorders

• Registration Number: NCT00694226
• Lead Sponsor: Hospital Clinic of Barcelona

Brief Summary

The objective of the study was to assess the efficacy in decreasing the likelihood of substance use of a brief motivational enhancement intervention in adolescents referred to psychiatric treatment.

237 adolescents consecutively admitted to a psychiatry department completed an evaluation of their substance use. Subjects identified as users were randomly allocated to one of two groups: an experimental group that received a brief intervention aimed at increasing their awareness of the risks of substance use, or a control group. All subjects received standard treatment according to the primary diagnosis. Structured questionnaires assessing knowledge, attitudes, perception of risks and intention of use of psychoactive substances were administered upon admission and 1 month later.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-03
• Primary Completion: 2005-09
• Study First Submitted: 2008-05-23
• Status Verified: 2008-06
• Study First Submitted QC: 2008-06-09
• Last Update Submitted: 2008-06-09
• Study First Posted: 2008-06-10
• Last Update Posted: 2008-06-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 143

Inclusion Criteria

• Subjects aged 12-17
• consecutively referred for psychiatric or psychological assessment and treatment to a Child and Adolescent Psychiatry and Psychology Department

Exclusion Criteria

• Not willing to take part.
• Mentally retarded
• Non completion of a substantial part of the assessment protocol.
• Presenting severe acute psychopathological disturbances that interfere with the assessment.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Attitudes towards psychoactive substances (Knowledge, Risk perception, Problems and Intention of use) measured with questionnaires obtained from the Evaluation Instruments Bank (EIB), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).	1 month

Trial Locations

Locations (1)

Hospital Clinic Barcelona; 🇪🇸 Barcelona, Spain